cardio
Anatomy and Physiology of Cardiac Conduction
Cardiac Chamber Structure and Pathway:
The heart consists of four chambers: Right Atrium, Left Atrium, Right Ventricle, and Left Ventricle.
The physiological electrical conduction pathway flows sequentially: Sinoatrial (SA) node Atrioventricular (AV) node Bundle of His $rightarrow Purkinje fibers.\n * **Sinoatrial (SA) Node**: Located in the right atrium; serves as the primary intrinsic pacemaker of the heart, initiating electrical impulses.\n * **Atrioventricular (AV) Node**: Receives impulses from the SA node and delays conduction to allow atrial contraction prior to ventricular excitation.\n * **Bundle of His and Purkinje Fibers**: Rapidly conduct electrical impulses through the ventricular septum and myocardium to trigger coordinated ventricular contraction.\n\n* **Conduction Timing and Intervals**:\n * Ideal electrical impulse transmission time from the SA node to the AV node (represented by the PR interval) is 0.12\,s\text{ to }0.20\,s.\n * Normal ventricular depolarization time (QRS complex duration) is less than 0.12\,s0.06\,s\text{ to }0.10\,s).\n\n* **Tissue Layers and Vascularization**:\n * **Heart Layers**: Endocardium (inner layer), Myocardium (thick middle muscular layer providing contractile force), and Epicardium (outer layer).\n * **Coronary Arteries**: Main arteries supplying oxygenated blood to the myocardium. Critical in surgical interventions such as Coronary Artery Bypass Graft (CABG), where graft vessels bypass occluded main coronary arteries to re-establish myocardial perfusion.\n\n# Hemodynamics and Cardiac Cycle\n\n* **Cardiac Cycle Phases**:\n * **Systole**: Phase of chamber contraction where blood is actively pumped out of the atria or ventricles.\n * **Diastole**: Phase of chamber relaxation and repolarization where chambers fill with blood.\n * **Systolic vs. Diastolic Blood Pressure**: For a blood pressure reading of 120/80\,mmHg120\,mmHg80\,mmHg represents arterial pressure during ventricular relaxation (diastole).\n\n* **Hemodynamic Parameters**:\n * **Cardiac Output (COCO = \text{Heart Rate (HR)} \times \text{Stroke Volume (SV)}5\text{ to }6\,L/min per ventricle.\n * **Stroke Volume (SV)**: The volume of blood ejected by one ventricle with each individual heartbeat. Determined by three primary physiological factors:\n * **Preload**: The degree of stretch on the ventricular muscle fibers at the end of diastole (end-diastolic volume/pressure).\n * **Afterload**: The systemic vascular resistance or arterial pressure that the ventricle must overcome to eject blood into the aorta or pulmonary artery.\n * **Contractility**: The intrinsic force generated by the myocardium to contract during systole. Positive inotropic agents (e.g., cardiac glycosides such as digoxin) enhance myocardial contractility force.\n\n* **Auscultation of Heart Sounds**:\n * **S_1 (First Heart Sound)**: The sound produced by the closure of the atrioventricular (AV) valves (mitral and tricuspid) at the start of systole ("lub").\n * **S_2S_1S_2 as present.\n * **S_321\text{--}22\text{ years of age}S_3 indicates pathological volume overload or heart failure.\n * **S_4 (Fourth Heart Sound)**: Atrial gallop occurring late in diastole, caused by atrial contraction against a non-compliant or stiff ventricle.\n\n# Diagnostic Tools and Electrocardiography (ECG)\n\n* **ECG Waveform Components**:\n * **P Wave**: Represents atrial depolarization (atrial contraction).\n * **QRS Complex**: Represents ventricular depolarization (ventricular contraction). Normal duration is 0.06\,s\text{ to }0.10\,s< 0.12\,s).\n * **T Wave**: Represents ventricular repolarization (ventricular relaxation/resting state).\n * **QT Interval**: Measures the total time required for ventricular depolarization and repolarization. Prolongation of the QT interval (a known adverse effect of central nervous system stimulants used in ADHD treatment) increases the risk for dangerous ventricular dysrhythmias.\n\n* **ECG Paper Grid Calibration**:\n * 1\text{ small box}0.04\,s\n * 1\text{ large box (5 small boxes)}0.20\,s\n\n* **Heart Rate Calculation Method (6\text{-Second Strip})**:\n * Count the total number of QRS complexes within a 6\text{-second}10bpm).\n * Calculation Examples:\n * 4\text{ complexes} \times 10 = 40\,bpm\n * 6\text{ complexes} imes 10 = 60\,bpm\n * 13\text{ complexes} \times 10 = 130\,bpm\n * 20\text{ complexes} \times 10 = 200\,bpm\n\n* **Ambulatory Diagnostic Monitoring**:\n * **Holter Monitor**: A wearable, non-invasive diagnostic device continuously recording ECG rhythms over a period of 24\text{ to }48\,h (not days). Used outpatient to evaluate paroxysmal palpitations, transient arrhythmias, or unexplained lightheadedness.\n\n# Sinus Arrhythmias\n\n* **Normal Sinus Rhythm (NSR)**:\n * **Rate**: 60\text{ to }100\,bpm\n * **Rhythm**: Regular\n * **P Wave**: Present, upright, uniform morphology preceding every QRS complex\n * **PR Interval**: 0.12\text{ to }0.20\,s\n * **QRS Duration**: Less than 0.12\,s\n\n* **Sinus Bradycardia**:\n * **Rate**: 40\text{ to }60\,bpm60\,bpm\n * **Rhythm & Waveform**: Regular rhythm, normal P-QRS-T sequence originating from the SA node.\n * **Physiological Manifestations**: May be asymptomatic in trained athletes (e.g., marathon runners with baseline HR 55\text{--}56\,bpm due to increased stroke volume).\n * **Clinical Presentation (Symptomatic)**: Dizziness, lightheadedness, fatigue, shortness of breath, hypotension, decreased cardiac output, increased risk of fall injuries.\n * **Nursing & Emergency Management**:\n * Investigate underlying causes (e.g., beta-blocker administration such as metoprolol, vagal tone, lifestyle factors).\n * **Hospital Resuscitation Protocol**: For unstable or acutely symptomatic bradycardia, administer IV Atropine.\n * **Atropine Dosage**: Initial dose of 1\,mg3\text{ to }5\text{ minutes}3\,mg.\n\n* **Sinus Tachycardia**:\n * **Rate**: 100\text{ to }150\,bpm\n * **Rhythm & Waveform**: Regular rhythm, normal P-QRS-T morphology driven rapidly by the SA node.\n * **Etiology**: Anxiety, fever, hypovolemia/fluid loss, shock, hyperthyroidism, sympathomimetic drugs, amphetamines, atropine, caffeine, nicotine/smoking.\n * **Clinical Symptoms**: Palpitations, dizziness, elevated temperature, chest pain, dyspnea, decreased renal perfusion (reduced urine output), increased fall risk.\n * **Nursing Interventions & Patient Education**:\n * Instruct patient to request assistance prior to getting out of bed.\n * Implement slow position changes (dangling legs at bedside prior to standing) to prevent orthostasis.\n * Encourage smoking cessation (nicotine increases heart rate and damages vessel walls).\n * Coordinate prescription drug adjustments if medications cause tachycardia.\n * **Pharmacological & Invasive Management**: Slow AV conduction using medications such as adenosine, beta-blockers (e.g., metoprolol), diazepam, or lidocaine. Perform catheter ablation if pharmacological management fails.\n\n# Ventricular Arrhythmias and Emergency Interventions\n\n* **Premature Ventricular Contraction (PVC)**:\n * **Physiology**: An irritated ventricular ectopic focus fires an early impulse prior to SA node firing, causing premature ventricular contraction.\n * **ECG Morphology**: Wide, bizarre QRS complex lacking a preceding P wave, followed by a compensatory pause and a large T wave.\n * **Classification Patterns**:\n * **Bigeminy**: Every second beat is a PVC (alternating normal beat and PVC).\n * **Trigeminy**: Every third beat is a PVC (two normal beats followed by a PVC).\n * **Etiological Triggers**: Caffeine, alcohol, smoking/nicotine, amphetamines, cocaine, hypokalemia, hypomagnesemia, thyroid dysfunction.\n * **Symptoms**: Palpitations, lightheadedness, dizziness, shortness of breath, chest pain.\n * **Management & Nursing Actions**:\n * Eliminate stimulants (caffeine, alcohol, nicotine, illicit drugs).\n * Assess and correct electrolyte levels (potassium and magnesium).\n * Administer beta-blockers or antiarrhythmics (e.g., amiodarone).\n * Catheter ablation indicated if symptoms persist after 30\text{ days} of medical therapy.\n\n* **Ventricular Tachycardia (V-tach)**:\n * **Physiology**: Single irritable ventricular focus generating rapid, repetitive impulses at a rate of at least 150\,bpm\n * **ECG Morphology**: Rapid, wide, repetitive QRS complexes; P waves hidden within QRS complexes.\n * **Clinical Outcomes**: May self-resolve within 5\text{ to }10\,s. If sustained, severely compromises ventricular filling, stroke volume, and cardiac output.\n * **Progression**: If unresolved, deteriorates rapidly into Ventricular Fibrillation.\n\n* **Ventricular Fibrillation (V-fib)**:\n * **Physiology**: Extremely chaotic, rapid ventricular quivering with complete loss of organized myocardial contraction.\n * **ECG Morphology**: Chaotic, irregular baseline with no identifiable P waves, QRS complexes, or T waves.\n * **Clinical Outcomes**: Lethal "dying heart rhythm"; zero cardiac output; loss of consciousness and pulse within seconds.\n * **Emergency Interventions**: Immediate CPR, advanced cardiac life support, continuous monitoring, and emergency electrical shock (defibrillation).\n\n# Atrial Arrhythmias and Conduction Disorders\n\n* **Premature Atrial Contraction (PAC)**:\n * Ectopic atrial impulse firing earlier than the expected sinus beat.\n * ECG displays a premature P wave (which may look different or be buried in the preceding T wave) and a shortened PR interval.\n\n* **Supraventricular Tachycardia (SVT)**:\n * Rapid tachyarrhythmia originating above the ventricles with heart rates ranging between 150\text{ to }250\,bpm200\,bpm\n * **Triggers/Causes**: Hyperthyroidism (thyroid crisis/storm), diabetes mellitus, renal failure/end-stage renal disease, severe stress.\n * **Symptoms**: Palpitations, severe fatigue, presyncope, syncope, dyspnea, decreased urine output.\n * **Non-Pharmacological Vagal Maneuvers**:\n * Application of ice water/cold compress to the face.\n * Valsalva maneuver (holding breath and bearing down).\n * Carotid sinus massage.\n * Positioning patient supine with legs elevated.\n * **Pharmacological Management**: Administer IV Adenosine, diltiazem, esmolol, or beta-blockers.\n\n* **Atrial Fibrillation (A-fib)**:\n * **Physiology**: Multiple chaotic ectopic foci firing simultaneously in the atria (100\text{ to }175\,bpm atrial activity rate). Atria quiver rather than contract effectively, leading to atrial blood stasis and clot formation.\n * **ECG Morphology**: Absence of discrete P waves; irregular, fibrillatory baseline; unmeasurable PR interval; unable to measure QRS complexes cleanly; irregular ventricular response.\n * **Comorbidities & Risk Factors**: Obstructive sleep apnea (OSA requiring CPAP/BiPAP), age > 60\text{ years}, obesity, hypertension, congestive heart failure (CHF), diabetes mellitus, COPD, thyroid disease, chronic kidney disease, stroke history, uncontrolled hyperglycemia (elevates blood viscosity, impairing circulation).\n * **Clinical Manifestations**: Dizziness, hypotension, irregular pulse, exertional fatigue, syncope, lightheadedness, decreased urine output, peripheral fluid retention/weight gain.\n * **Diagnostic Laboratory Assessment**: Serum creatinine, blood glucose, INR, CBC, TSH, and free thyroxine (T_4\n * **Therapeutic Interventions**:\n * **Anticoagulation Therapy**: E.g., apixaban (Eliquis) 5\,mg12\text{-hour} dosing schedules due to drug half-life.\n * **Bleeding Precautions**: Educate patient to use a soft-bristled toothbrush, electric razor, and avoid contact sports or high-impact activities (e.g., bouldering).\n * **Rate/Rhythm Control**: Antiarrhythmic medications, beta-blockers, calcium channel blockers.\n * **Synchronized Electrocardioversion**: Scheduled procedure performed after 30\text{ days} of anticoagulation therapy. Patient must be NPO (to prevent aspiration), placed under general anesthesia/conscious sedation (as shocking conscious patients is painful), provided airway maintenance, and continuously monitored on ECG.\n\n* **Atrial Flutter**:\n * **Physiology**: Rapid atrial re-entrant circuit generating an atrial rate of 240\text{ to }400\,bpm. Ventricular rate depends on AV conduction ratio.\n * **ECG Morphology**: Classic, uniform "sawtooth" flutter waves (F waves) replacing P waves.\n * **Epidemiological Comparison**: Less common than Atrial Fibrillation.\n * **Etiology/Risk Factors**: Recent myocardial infarction (MI), post-cardiac surgery (e.g., stent replacement, valve replacement).\n * **Symptoms**: Dyspnea, palpitations, lightheadedness, exertional fatigue.\n\n# Heart Blocks (AV Conduction Defects)\n\n* **General Mechanism**:\n * Conduction delay or complete disruption of electrical impulses passing from the SA node through the AV node into the ventricles. PR interval exceeds upper limit of 0.20\,s0.30\,s\text{ to }0.40\,s\n\n* **First-Degree Heart Block**:\n * **Definition**: Prolonged conduction time through the AV node resulting in a constant PR interval greater than 0.20\,s\n * **Etiology**: History of myocardial infarction, hypokalemia, hypomagnesemia, acute infections (e.g., COVID-19, endocarditis), rheumatic fever, side effect of antiarrhythmic medications (digoxin, calcium channel blockers such as diltiazem, beta-blockers such as metoprolol, potassium channel blockers such as amiodarone).\n * **Clinical Management**: Frequently asymptomatic with minimal impact on cardiac output. Does not require invasive treatment immediately. Managed via ongoing ECG/symptom monitoring, adjustment of offending drugs, and lifestyle changes (avoiding fatigue, low-sodium/low-cholesterol diet).\n\n* **Third-Degree (Complete) Heart Block**:\n * **Definition**: Complete dissociation between atrial and ventricular conduction. No atrial impulses reach the ventricles.\n * **Physiology**: Atria and ventricles beat independently. Ventricles contract at an intrinsic escape rate, leading to severe bradycardia, significantly reduced cardiac output, severe hypotension, and hemodynamic collapse.\n * **Treatment**: Immediate insertion of a temporary or permanent surgical pacemaker to generate impulse and reset heart rate.\n\n# Pulseless Electrical Activity (PEA)\n\n* **Definition**: Clinical emergency where an organized or semi-organized electrical cardiac rhythm is displayed on the ECG monitor, but there is zero mechanical myocardial contraction and no palpable pulse.\n* **ECG Presentation**: Can display sinus rhythm, bradycardia, or wide QRS complexes without producing cardiac output or pulse.\n* **Reversible Etiologies (The H's and T's context)**:\n * Hypovolemia\n * Hypothermia\n * Hypoxia\n * Acidosis\n * Hyperkalemia / Hypokalemia (Potassium imbalance)\n* **Emergency Management**: Immediate CPR, airway management, continuous resuscitation, and urgent reversal of underlying causes. PEA is a non-shockable rhythm.\n\n# Advanced Cardiac Devices and Interventions\n\n* **Automated External Defibrillator (AED)**: Facility-based emergency defibrillator designed to analyze rhythm and deliver external shocks for lethal rhythms (V-tach, V-fib).\n* **Implantable Cardioverter Defibrillator (ICD)**: Surgically implanted device placed near the chest/heart; continuously monitors cardiac rhythm and automatically delivers an internal electrical shock upon detecting dangerous dysrhythmias.\n* **Wearable Cardioverter Defibrillator (LifeVest)**:\n * External wearable vest connected to a monitor that continuously tracks cardiac rhythm and delivers automatic shocks for lethal arrhythmias.\n * **Usage Protocol**: Patient must wear vest continuously at all times, removing it ONLY during showering/bathing due to electrical shock hazards.\n * **Emergency Warning**: Wirelessly linked to cardiology clinics. If battery failure or device malfunction occurs, patient must be transported to the Emergency Room immediately to prevent sudden cardiac death.\n* **Wireless Pacemaker**: Miniature leadless cardiac pacemaker inserted directly into the right ventricle to generate impulses and maintain rate.\n* **Catheter Ablation**:\n * Invasive catheterization procedure performed in the cardiac catheterization lab via femoral artery access.\n * Catheter advances to the heart to apply thermal/radiofrequency energy ("zap") and destroy defective, erratic conducting tissue or ectopic foci firing abnormally.\n * Allows the SA node to resume dominance over heart rhythm.\n * **Indication**: Performed as an outpatient or inpatient procedure typically after 30\text{ days} of unsuccessful pharmacological therapy.\n\n# Clinical Case Analyses and Pharmacological Decision-Making\n\n* **Case Study 1: Valvular Heart Disease Management**:\n * **Clinical Presentation**: Patient admitted with valvular heart disease, reporting 1 month of palpitations, fatigue, weakness, and an auscultated heart murmur. Assessment reveals clear lung sounds, unlabored breathing on 2\,L+22\text{-hour}SpO_2 drops. Echocardiogram confirms aortic valve stenosis.\n * **Pharmacological Evaluation**:\n * **Multivitamin**: Nonessential.\n * **Metoprolol (Beta-blocker)**: Anticipated (controls heart rate and reduces myocardial workload).\n * **Furosemide (Loop Diuretic)**: Anticipated (promotes fluid excretion for ascites, peripheral edema, and volume overload).\n * **Digoxin (Cardiac Glycoside)**: Anticipated (enhances myocardial contractility while slowing AV conduction).\n * **Acetaminophen**: Contraindicated (high risk of hepatotoxicity given existing hepatic congestion, ascites, and RUQ pain).\n * **Enalapril (ACE Inhibitor)**: Anticipated (reduces afterload and blood pressure in valvular heart disease).\n\n* **Case Study 2: Acute Myocardial Injury / Chest Pain Protocol**:\n * **Clinical Presentation**: Patient presenting at 03:0006:006/10130\,bpm), and sinus tachycardia on ECG.\n * **Diagnostic Biomarkers**: Troponin I elevated (> 0.3\,ng/mL> 0.1\,ng/mL), Creatine Kinase (CK) elevated, Myoglobin elevated. Indicates acute myocardial infarction/injury.\n * **Pharmacological Evaluation**:\n * **Aspirin (160\,mg)**: Essential (antiplatelet agent to inhibit further clot formation).\n * **Supplemental Oxygen (2\,L via Nasal Cannula)**: Essential (relieves myocardial hypoxia).\n * **Acetaminophen (650\,mg$$)**: Nonessential (ineffective for ischemic cardiac pain; nitroglycerin is required).
Nitroglycerin: Essential (coronary vasodilator to restore blood flow and reduce ischemic pain).
Pseudoephedrine: Contraindicated (sympathomimetic nasal decongestant that elevates blood pressure and heart rate, severely worsening myocardial ischemia).